TLR1 and neoplasm: Pam3CSK4, a TLR1/TLR2 ligand can induce tumor remission in severe combined immunodeficiency (SCID) mice by diminishing the suppressive function of Foxp3+ Treg cells and enhancing the cytotoxicity of tumor-specific CTLs.